A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-04-15) →
What happened
Access Bio updated the disclosed terms of an acquisition of RF Bio Co., Ltd., now worth US$37.8M.
For context, this deal is worth about 7.7% of the company's own total assets.
| Target | RF Bio Co., Ltd. |
|---|---|
| Deal value | US$37.8M |
| vs. company assets | 7.7% |
| Filed | 2026-03-27, [Amended] Decision to acquire shares/equity in another company |
| Source | DART rcept 20260327900925 → open original filing |
Versions of this filing
- 2026-01-19Original
- 2026-03-27Amendment 1 (this page)
- 2026-04-15Amendment 2
Source: DART. Information only, not investment advice.